Our study further revealed that METTL3‐positive AML patients had increased WBC counts at initial diagnosis and often had DNMT3A mutations (Table S4), suggesting that there are some correlations between m6A and DNA methylation. The gene discussed is METTL3; the disease is acute myeloid leukemia.